These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12525346)

  • 1. [Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis].
    Pérez Prim FJ; Vila I
    Aten Primaria; 2002 Dec; 30(10):663-4. PubMed ID: 12525346
    [No Abstract]   [Full Text] [Related]  

  • 2. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
    Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
    Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Oropharyngeal Candidiasis: From Etiology to Current Treatment.
    Qadir MI; Bashir H; Ahmad MH
    Crit Rev Immunol; 2023; 43(3):15-24. PubMed ID: 37824374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME
    Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrush and breastfeeding.
    Shepherd J
    Pract Midwife; 2002 Dec; 5(11):24-7. PubMed ID: 12520814
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
    Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole in oesophageal reflux disease.
    Dawson R; Manson JM
    Lancet; 2000 Nov; 356(9243):1770-1. PubMed ID: 11095286
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune haemolytic anaemia associated with use of omeprazole.
    Butt MI; Sajid S; Sobolewski S
    Br J Hosp Med (Lond); 2007 Feb; 68(2):108. PubMed ID: 17370722
    [No Abstract]   [Full Text] [Related]  

  • 14. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
    Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
    Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term omeprazole treatment and risk of gastric cancer.
    Cammarota G; Cianci R; Gasbarrini G
    Gastroenterology; 2000 Oct; 119(4):1176-7. PubMed ID: 11203031
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune haemolytic anaemia due to Omeprazole.
    Butt MI; Sajid S; Sobolewski S
    Ir Med J; 2007 Feb; 100(2):372. PubMed ID: 17432815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of oropharyngeal candidiasis in HIV-positive patients.
    Greenspan D
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S51-5. PubMed ID: 7915732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of omeprazole on the gastric mucosa.
    Driman DK; Tougas G; Riddell R
    Gastroenterology; 2000 Oct; 119(4):1176. PubMed ID: 11203030
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease.
    Kuipers EJ; Meuwissen SG
    Gastroenterology; 2000 Apr; 118(4):795-8. PubMed ID: 10734031
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.